Enhancer of Zeste homolog 2（EZH2） is closely correlated with malignant tumor and regarded as a promising target to treat B-cell lymphoma. In our research, the molecular docking and three-dimensional quantitative str...Enhancer of Zeste homolog 2（EZH2） is closely correlated with malignant tumor and regarded as a promising target to treat B-cell lymphoma. In our research, the molecular docking and three-dimensional quantitative structure-activity relationships（3D-QSAR） studies were performed on a series of pyridone-based EZH2 compounds. Molecular docking allowed us to study the critical interactions at the binding site of EZH2 protein with inhibitors and identify the practical conformations of ligands in binding pocket. Moreover, the docking-based alignment was applied to derive the reliable 3D-QSAR models. Comparative molecular field analysis（CoMFA） and comparative molecular similarity indices analysis（CoMSIA） provided available ability of visualization. All the derived 3D-QSAR models were considered to be statistically significant with respect to the internal and external validation parameters. For the CoMFA model, q^2 = 0.649, r^2 = 0.961 and r^2 pred = 0.877. For the CoMSIA model, q^2 = 0.733, r^2 = 0.980 and r^2 pred = 0.848. With the above arguments, we extracted the correlation between the biological activity and structure. Based on the binding interaction and 3D contour maps, several new potential inhibitors with higher biological activity predicted were designed, which still awaited experimental validation. These theoretical conclusions could be helpful for further research and exploring potential EZH2 inhibitors.展开更多
基金supported by the National Natural Science Foundation of China(No.81270054)the program for Outstanding Young Teachers in Higher Education Institutions of Guangdong Province(No.Yq2013045)
文摘Enhancer of Zeste homolog 2（EZH2） is closely correlated with malignant tumor and regarded as a promising target to treat B-cell lymphoma. In our research, the molecular docking and three-dimensional quantitative structure-activity relationships（3D-QSAR） studies were performed on a series of pyridone-based EZH2 compounds. Molecular docking allowed us to study the critical interactions at the binding site of EZH2 protein with inhibitors and identify the practical conformations of ligands in binding pocket. Moreover, the docking-based alignment was applied to derive the reliable 3D-QSAR models. Comparative molecular field analysis（CoMFA） and comparative molecular similarity indices analysis（CoMSIA） provided available ability of visualization. All the derived 3D-QSAR models were considered to be statistically significant with respect to the internal and external validation parameters. For the CoMFA model, q^2 = 0.649, r^2 = 0.961 and r^2 pred = 0.877. For the CoMSIA model, q^2 = 0.733, r^2 = 0.980 and r^2 pred = 0.848. With the above arguments, we extracted the correlation between the biological activity and structure. Based on the binding interaction and 3D contour maps, several new potential inhibitors with higher biological activity predicted were designed, which still awaited experimental validation. These theoretical conclusions could be helpful for further research and exploring potential EZH2 inhibitors.
